Acute Myeloid Leukemia
The AML SWG represents a group of nationally and internationally renowned experts working in the field of AML. Our major aim is to provide a forum for translational research by bridging the gaps between basic scientists and clinicians treating AML patients.
Our activities include the design of clinical studies, studies on supportive care and quality of life aspects, development of guidelines/recommendations, as well as a broad spectrum of research initiatives with a focus on the characterization of the genomic landscape of AML (genomic/multiomic and functional). We also aim to contribute to collecting and linking harmonized real-world datasets to promote precision medicine and the generation of reliable evidence for regulatory and research purposes.
We will expand the already well-established international AML network and initiate novel cooperation and research activities. We attach great importance to the integration and development of young AML researchers and clinicians. We will provide them with networking opportunities and involve them in clinical and research activities at an early stage of their career, thus developing the future European thought leaders in AML.
Finally, operating under the umbrella of EHA, the SWG AML is closely involved in numerous EHA activities (e.g. education, research, European affairs, and health technology assessment)
Become a registered member of this Specialized Working Group: Apply here